Netherlands· NL-6ea44feb5ba0
A. Vogel Aesculaforce tabletten
A hippocastani semen product containing aesculus hippocastanum semen ethanol-water (60-40) droog extract, der (7,1-11,2 = 1), registered in Netherlands by A.Vogel B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Hippocastani semen is registered in 7 of 19 countries.
Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Hippocastani semen · ATC C05CX03
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AESCULUS HIPPOCASTANUM SEMEN ETHANOL-WATER (60-40) DROOG EXTRACT, DER (7,1-11,2 = 1)
- Manufacturer
- A.Vogel B.V.
- Country
- Netherlands (NL)
- ATC code
- C05CX03
- ATC class
- Hippocastani semen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id100864
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hippocastani semen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAesculus (White Chestnut)Bestmade Natural Products
- BelgiumAesculus Hippocastanum Boiron 200KBoiron
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- PolandEscevenPoznańskie Zakłady Zielarskie "Herbapol" S.A.
- FinlandAESCULUS Alfaplex (Al 12)
- FranceELUSANES MARRONNIER D'INDE, gélulePIERRE FABRE MEDICAMENT
- SpainCASTAÑO DE INDIAS ARKOPHARMA cápsulas durasArkopharma Laboratorios S.A.U.
- GermanyVenen-AktivPharma Aldenhoven Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Venen-Aktiv
- Italy · Flebostasin R
- Poland · Esceven, Hiposem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/81b8668d-18fb-47d3-a649-7150c1e5fff9 GET /v1/drugs/81b8668d-18fb-47d3-a649-7150c1e5fff9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100864_smpc.pdf",
"strength": null,
"atc_label": "Hippocastani semen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100864",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
"COPOVIDON (E 1208)",
"MAÏSZETMEEL",
"POLYSACCHARIDEN VAN SOJA",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TRIETHYLCITRAAT (E 1505)"
],
"substances": [
"AESCULUS HIPPOCASTANUM SEMEN ETHANOL-WATER (60-40) DROOG EXTRACT, DER (7,1-11,2 = 1)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100864.pdf",
"authorised_at": "2009/09/10",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "100864",
"additional_monitoring": "N"
}See everything about hippocastani semen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.